Search alternatives:
significant lack » significant gap (Expand Search), significant loss (Expand Search), significant impact (Expand Search)
mean decrease » a decrease (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
lack based » slack based (Expand Search), place based (Expand Search), block based (Expand Search)
Showing 21 - 40 results of 22,833 for search '(( significant lack based ) OR ( significant ((gap decrease) OR (mean decrease)) ))', query time: 0.59s Refine Results
  1. 21
    Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year.

    Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 22
    Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease).

    Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “... by Mobina Faqani (22783963)

    Published 2025
    Save to List
    Saved in:
  3. 23
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 24
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 25
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 26
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 27
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 28
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 29
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 30
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 31
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 32
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 33
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 34
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 35
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 36
    The number of gauging cross-sections where a statistically significant decreasing trend was identified.

    The number of gauging cross-sections where a statistically significant decreasing trend was identified. by Krzysztof Kochanek (835532)

    Published 2024
    Save to List
    Saved in:
  17. 37
    Lack of T3SS expression was associated with lower S10 expression.

    Lack of T3SS expression was associated with lower S10 expression. by Justin Greene (306625)

    Published 2025
    Save to List
    Saved in:
  18. 38
    Mean decrease Gini score by Tweet and user characteristics.

    Mean decrease Gini score by Tweet and user characteristics. by Gray Babbs (16648894)

    Published 2023
    Save to List
    Saved in:
  19. 39
    Decrease of the mean number of natural teeth and POPs with age.

    Decrease of the mean number of natural teeth and POPs with age. by Sul-Hee Kim (11873853)

    Published 2021
    Save to List
    Saved in:
  20. 40
    Gap junction (GJ) communication decreases the proportion of cells exhibiting Ca<sup>2+</sup> spikes.

    Gap junction (GJ) communication decreases the proportion of cells exhibiting Ca<sup>2+</sup> spikes. by Dharsan K. Soundarrajan (11632145)

    Published 2021
    Save to List
    Saved in:

Search Tools: